Nutrients 13 , 3466 (2021)
The ASCO GI 2026 data suggest that GLP-1 therapy may be particularly relevant for metabolically high-risk populations, including individuals with obesity, insulin resistance, or type 2 diabetesgroups that now account for a substantial proportion of colorectal cancer burden
Some Are Considering It Yale New Haven Health: Should You Suddenly Stop Taking GLP-1s
Build Better Biology Peptide Stacks at Prefusion Health are designed for people who want clarity, structure, and measurable progress
Mitochondrial inhibition may play a key role in the activities of berberine such as preventing fatty liver, reducing blood glucose and decreasing blood lipids
Key takeaways GLP-1 medications, such as those with semaglutide, may help you lose weight thats gained during perimenopause or menopause